Diabetes in Pregnancy, Gestational Diabetes, Texting Interventions
Conditions
Brief summary
Maternal diabetes in pregnancy can negatively impact fetal well-being and contribute to adverse pregnancy outcomes. Much of the morbidity associated with diabetes in pregnancy can be minimized with tight glucose control. A number of studies in non-pregnant populations have highlighted the feasibility, acceptability and efficacy of text messaging interventions for improving diabetic compliance and control. This study will investigate whether a text messaging intervention is feasible and effective in an urban, diabetic, obstetric clinic and whether this intervention can improve compliance with diabetes care, glucose control and pregnancy outcomes. The study will also assess satisfaction with the intervention itself.
Interventions
BEHAVIORALText Message Intervention
Sponsors
University of Pennsylvania
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Eligibility
Sex/Gender
FEMALE
Age
18 Years to 50 Years
Healthy volunteers
No
Inclusion criteria
* Pregnant women aged 18-50 years * Planned delivery at Hospital of the University of Pennsylvania
Exclusion criteria
* Gestational age greater than 34 weeks at initial visit in the Penn Perinatal Diabetes Program * Women who are unable to read English as all text messages will be in English * Women who do not have a cellular phone capable of receiving text messages as this is the study intervention
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Patient Satisfaction | date of enrollment up to 12 weeks post partum | Patient satisfaction with the texting intervention as measured by a post-study survey |
| Compliance with Obstetric and Diabetes Care | OB screening visit through 12 weeks postpartum | Proportion of prenatal visits attended, proportion of assigned blood glucose logs sent to clinic for review, proportion of assigned blood glucose values checked, compliance with attendance at postpartum visit. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Efficacy measures | Diabetes diagnosis through 12 weeks postpartum | Measuring the proportion of blood glucose values within the target range each week; mean fasting and postprandial blood glucose values measured weekly; change in hemoglobin A1C (for pregestational diabetics) from initiation of care to the third trimester |
| Healthcare Utilization Measures | Screening OB visit through 12 weeks postpartum | Measuring the number of visits to the perinatal evaluation center related to diabetes care and the total number of antepartum hospitalizations. |
| Maternal Outcomes | Delivery date through 12 weeks postpartum | Measuring the mode of delivery (spontaneous vaginal, operative vaginal, cesarean section), complications of delivery (shoulder dystocia, postpartum hemorrhage, third and fourth degree lacerations), and length of hospital stay. |
| Neonatal Outcomes | Neonate delivery through 12 weeks postpartum | Measuring fetal demise; neonatal death; birthweight; large for gestational age; small for gestational age; APGAR scores; umbilical cord blood gas; NICU admission; respiratory distress; hypoglycemia; hyperbilirubinemia; length of hospital stay |
Countries
United States
Outcome results
None listed